Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer

Cisplatin-based combinations are efficacious in increasing the overall survival of patients with non-small cell lung cancer (NSCLC), but their toxicity makes them unsuitable for elderly and unfit patients. The primary objective of this non-randomized phase II study was to evaluate the feasibility an...

Descripción completa

Detalles Bibliográficos
Autores principales: Beretta, G D, Michetti, G, Belometti, M O, Gritti, G, Quadri, A, Poletti, P, Labianca, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363520/
https://www.ncbi.nlm.nih.gov/pubmed/10944594
http://dx.doi.org/10.1054/bjoc.2000.1304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363520/
https://www.ncbi.nlm.nih.gov/pubmed/10944594
http://dx.doi.org/10.1054/bjoc.2000.1304

Ejemplares similares